Growth Metrics

Pfizer (PFE) Treasury Shares (2016 - 2025)

Pfizer (PFE) has disclosed Treasury Shares for 17 consecutive years, with $115.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares changed 0.22% to $115.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $115.0 billion, a 0.22% change, with the full-year FY2025 number at $115.0 billion, changed 0.22% from a year prior.
  • Treasury Shares was $3.9 billion for Q4 2025 at Pfizer, roughly flat from $3.9 billion in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.9 billion in Q1 2025 to a low of $39.0 million in Q2 2022.
  • A 5-year average of $3.7 billion and a median of $3.9 billion in 2023 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: increased 2.34% in 2022, then rose 0.22% in 2025.
  • Pfizer's Treasury Shares stood at $111.4 billion in 2021, then increased by 2.34% to $114.0 billion in 2022, then increased by 0.45% to $114.5 billion in 2023, then increased by 0.24% to $114.8 billion in 2024, then increased by 0.22% to $115.0 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Treasury Shares are $115.0 billion (Q4 2025), $115.0 billion (Q3 2025), and $115.0 billion (Q2 2025).